ArticleEClinicalMedicine2020

Imatinib improved the overall survival of chronic myeloid leukemia patients in low- and middle-income countries: A therapeutic goal has been reached.

Massimo BrecciaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.